Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

SHA:688639 Revenue

Anhui Huaheng Biotechnology had revenue of 771.26M CNY in the quarter ending March 31, 2026, with 12.26% growth. This brings the company's revenue in the last twelve months to 2.95B, up 24.61% year-over-year. In the year 2025, Anhui Huaheng Biotechnology had annual revenue of 2.86B with 31.40% growth.

• Revenue (ttm): 2.95B
• Revenue Growth: +24.61%
• P/S Ratio: 2.36
• Revenue / Employee: 1.31M
• Employees: 2,252
• Market Cap: 6.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.86B	683.90M	31.40%
Dec 31, 2024	2.18B	239.67M	12.37%
Dec 31, 2023	1.94B	519.62M	36.63%
Dec 31, 2022	1.42B	464.56M	48.69%
Dec 31, 2021	954.10M	466.85M	95.81%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error